SCHEMBL14701769

SCHEMBL14701769

CC(F)(F)C(=O)OCC(C)(O)C(=O)OC1(C(C)(C)C)C2CC3CC(C2)CC1C3

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CYP17A1 P05093 1/20 0.32
CYP19A1 P11511 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14703975 0.87
SCHEMBL14701773 0.85 CYP17A1 (0.42) CYP17A1CYP19A1
SCHEMBL14701772 0.84
SCHEMBL14701770 0.83
SCHEMBL14701762 0.81 CYP19A1 (0.40) CYP17A1CYP19A1
SCHEMBL14701774 0.73 CYP17A1 (0.33) CYP17A1CYP19A1
SCHEMBL685888 0.73 CYP17A1 (0.43) CYP17A1CYP19A1
SCHEMBL13475059 0.73 CYP17A1 (0.36) CYP17A1CYP19A1
SCHEMBL14704048 0.73 CYP17A1 (0.38) CYP17A1CYP19A1
SCHEMBL14703970 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9051251-B2 Salt, photoresist composition and method for producing photoresist pattern SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2015-06-09 US disclosed
US-20130040237-A1 SALT, PHOTORESIST COMPOSITION AND METHOD FOR PRODUCING PHOTORESIST PATTERN SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2013-02-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130040237-A1 SALT, PHOTORESIST COMPOSITION AND METHOD FOR PRODUCING PHOTORESIST PATTERN F12, C1S, FRG1 CYP17A1 2059/4885CYP19A1 2743/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.